Journal of Cachexia Sarcopenia and Muscle

Article	Citations
Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis	463
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021	318
Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults	216
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review	177
Understanding the gut microbiota and sarcopenia: a systematic review	145
Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19	127
Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysis	125
Effects of statins on mitochondrial pathways	105
The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.	104
Mouse models of sarcopenia: classification and evaluation	96
Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers	92
Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis	91
Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study	88
Muscle wasting as an independent predictor of survival in patients with chronic heart failure	79
Muscular weakness and muscle wasting in the critically ill	79
Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality	79
Systematic review and meta‐analysis of protein intake to support muscle mass and function in healthy adults	78
Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosis	78
Gut microbes and muscle function: can probiotics make our muscles stronger?	77
Associations of low handgrip strength with cancer mortality: a multicentre observational study	77
Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting	73
Inhibition of the NLRP3/IL‐1β axis protects against sepsis‐induced cardiomyopathy	70
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients	69
Sarcopenia and peripheral arterial disease: a systematic review	67
Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta‐analysis	65

Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS	64
Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China	62
Single‐cell RNA sequencing and lipidomics reveal cell and lipid dynamics of fat infiltration in skeletal muscle	62
Roles of nutrition in muscle health of community‐dwelling older adults: evidence‐based expert consensus from Asian Working Group for Sarcopenia	62
Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial	61
Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study	61
Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study	61
Computed tomography‐defined low skeletal muscle index and density in cancer patients: observations from a systematic review	61
Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short‐chain fatty acid butyrate among healthy menopausal women	60
Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID‐19: a prospective observational study	58
Improving rehabilitation in sarcopenia: a randomized‐controlled trial utilizing a muscle‐targeted food for special medical purposes	58
Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis	56
Exercise for sarcopenia in older people: A systematic review and network meta‐analysis	55
Normative values of muscle strength across ages in a ‘real world’ population: results from the longevity check‐up 7+ project	55
Age‐related decline of interferon‐gamma responses in macrophage impairs satellite cell proliferation and regeneration	54
Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?	54
How gait influences frailty models and health‐related outcomes in clinical‐based and population‐based studies: a systematic review	53
Muscle memory: myonuclear accretion, maintenance, morphology, and miRNA levels with training and detraining in adult mice	53
Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross‐sectional survey (NutriAgeCancer)	52
Probiotic supplementation attenuates age‐related sarcopenia via the gut–muscle axis in SAMP8 mice	51
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi‐cohort analysis	50
Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia	49
Metformin induces muscle atrophy by transcriptional regulation of myostatin via HDAC6 and FoxO3a	47
Effect of vitamin D monotherapy on indices of sarcopenia in community‐dwelling older adults: a systematic review and meta‐analysis	47
ACSL4 contributes to ferroptosis‐mediated rhabdomyolysis in exertional heat stroke	46
The effect of fasting or calorie restriction on mitophagy induction: a literature review	46
Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐7	46
Muscle density discriminates hip fracture better than computed tomography X‐ray absorptiometry hip areal bone mineral density	45
Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies	44
Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer	43
Age‐related alterations in muscle architecture are a signature of sarcopenia: the ultrasound sarcopenia index	43
A systematic review examining the relationship between cytokines and cachexia in incurable cancer	43
Muscle strength and incidence of depression and anxiety: findings from the UK Biobank prospective cohort study	43
The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review	43
The impact of sarcopenia and acute muscle mass loss on long‐term outcomes in critically ill patients with intra‐abdominal sepsis	42
Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models	42
Meta‐analysis of genome‐wide DNA methylation and integrative omics of age in human skeletal muscle	42
Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome	42
TMEM182 interacts with integrin beta 1 and regulates myoblast differentiation and muscle regeneration	41
The beneficial therapeutic effects of plant‐derived natural products for the treatment of sarcopenia	41
Prognostic impact of muscle and fat mass in patients with heart failure	40
Longitudinal association of sarcopenia and mild cognitive impairment among older Mexican adults	39
Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire	39
Higher dietary fibre intake is associated with increased skeletal muscle mass and strength in adults aged 40 years and older	38
Handgrip strength and all‐cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study	38
Incidence of cardiovascular disease and mortality in underweight individuals	38
Myogenesis modelled by human pluripotent stem cells: a multi‐omic study of Duchenne myopathy early onset	37
lncMGPF is a novel positive regulator of muscle growth and regeneration	37
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer	37
Mitochondrial dysfunction in skeletal muscle contributes to the development of acute insulin resistance in mice	37

Associations of osteoporosis and sarcopenia with frailty and multimorbidity among participants of the Hertfordshire Cohort Study	37
Cancer cachexia in a mouse model of oxidative stress	36
Relative sit‐to‐stand power: aging trajectories, functionally relevant cut‐off points, and normative data in a large European cohort	36
Associations between inflammatory markers, body composition, and physical function: the Copenhagen Sarcopenia Study	36
Severe loss of mechanical efficiency in COVID‐19 patients	36
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper fromthe International Lipid Expert Panel(ILEP)	36
Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual‐energy X‐ray absorptiometry	36
Activation of Akt–mTORC1 signalling reverts cancer‐dependent muscle wasting	36
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin	35
circRNAome profiling reveals circFgfr2 regulates myogenesis and muscle regeneration via a feedback loop	35
Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction	35
Sarcopenia and health‐related quality of life: A systematic review and meta‐analysis	34
Red meat consumption and risk of frailty in older women	34
Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes	34
Prevalence and factors associated with poor performance in the 5‐chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of	34
Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand	34
Effects of resistance training intensity on muscle quantity/quality in middle‐aged and older people: a randomized controlled trial	34
Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review	33
Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia	33
Female mice may have exacerbated catabolic signalling response compared to male mice during development and progression of disuse atrophy	33
Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo‐controlled D‐Health Trial	33
Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice	32
AKT controls protein synthesis and oxidative metabolism via combined mTORC1 and FOXO1 signalling to govern muscle physiology	32
High levels of modified ceramides are a defining feature of murine and human cancer cachexia	32
Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research	32
Muscle strength is associated with COVID‐19 hospitalization in adults 50 years of age or older	32
Effects of β‐hydroxy β‐methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review	32
Satellite cell self‐renewal in endurance exercise is mediated by inhibition of mitochondrial oxygen consumption	31
Decoding the transcriptome of denervated muscle at single‐nucleus resolution	31
Diagnostic test accuracy of ultrasound for sarcopenia diagnosis: A systematic review and meta‐analysis	31
Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?	31
Multi‐compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice	31
Predicted fat mass and lean mass in relation to all‐cause and cause‐specific mortality	30
Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia	30
Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants	30
Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications	30
Ribosome biogenesis and degradation regulate translational capacity during muscle disuse and reloading	30
Role of sarcopenia in the frailty transitions in older adults: a population‐based cohort study	30
Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma	30
Autophagy in muscle regeneration: potential therapies for myopathies	30
Associations of low hand grip strength with 1 year mortality of cancer cachexia: a multicentre observational study	30
Twelve‐year sarcopenia trajectories in older adults: results from a population‐based study	30
Handgrip strength asymmetry is associated with the risk of neurodegenerative disorders among Chinese older adults	29
Population‐based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study	29
The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation	29
Association between muscle strength and advanced fibrosis in non‐alcoholic fatty liver disease: a Korean nationwide survey	29
Diverging metabolic programmes and behaviours during states of starvation, protein malnutrition, and cachexia	29
Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study	29
Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin	29
Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease	29
Total and regional fat‐to‐muscle mass ratio measured by bioelectrical impedance and risk of incident type 2 diabetes	29
The effect of short‐term exercise prehabilitation on skeletal muscle protein synthesis and atrophy during bed rest in older men	29
Absolute and relative grip strength as predictors of cancer: prospective cohort study of 445 552 participants in UK Biobank	28
Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer‐induced cachexia	28
Muscle‐to‐fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity	28
Mitochondrial uncoupling attenuates sarcopenic obesity by enhancing skeletal muscle mitophagy and quality control	28
Adverse muscle composition predicts all‐cause mortality in the UK Biobank imaging study	28
Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey	28
Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study	28
The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta‐analysis	28
ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia	28
Association between skeletal muscle mass and quality of life in adults with cancer: a systematic review and meta‐analysis	28
Home‐based aerobic exercise and resistance training for severe chronic kidney disease: a randomized controlled trial	27
A systematic review and meta‐analysis of the prevalence and correlation of mild cognitive impairment in sarcopenia	26
Inflammation‐induced cholestasis in cancer cachexia	26
Sarcopenia as potential biological substrate of long COVID‐19 syndrome: prevalence, clinical features, and risk factors	26
The ability of eight frailty instruments to identify adverse outcomes across different settings: the FRAILTOOLS project	26
Declines in muscle protein synthesis account for short‐term muscle disuse atrophy in humans in the absence of increased muscle protein breakdown	26
Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma	25
Intramuscular adipose tissue in the quadriceps is more strongly related to recovery of activities of daily living than muscle mass in older inpatients	25
Protein intake and risk of frailty among older women in the Nurses' Health Study	25
Impact of high‐intensity interval training with or without l‐citrulline on physical performance, skeletal muscle, and adipose tissue in obese older adults	25
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy	25
Muscle density is an independent risk factor of second hip fracture: a prospective cohort study	25
Single‐cell deconstruction of post‐sepsis skeletal muscle and adipose tissue microenvironments	24
Mesenchymal stromal cells ameliorate diabetes‐induced muscle atrophy through exosomes by enhancing AMPK/ULK1‐mediated autophagy	24
Effects of sarcopenia and malnutrition on morbidity and mortality in gynecologic cancer surgery: results of a prospective study	24
Nampt activator P7C3 ameliorates diabetes and improves skeletal muscle function modulating cell metabolism and lipid mediators	24
Molecular mechanisms of cancer cachexia‐related loss of skeletal muscle mass: data analysis from preclinical and clinical studies	24
Sarcopenia and cardiovascular diseases: A systematic review and meta‐analysis	24

Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients	24
Impact of probiotics on muscle mass, muscle strength and lean mass: a systematic review and meta‐analysis of randomized controlled trials	24
Advanced oxidation protein products contribute to chronic kidney disease‐induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway	23
Muscle strength and prediabetes progression and regression in middle‐aged and older adults: a prospective cohort study	23
Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease	23
The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients	23
Metabolic profiling shows pre‐existing mitochondrial dysfunction contributes to muscle loss in a model of ICU‐acquired weakness	23
Exogenous insulin‐like growth factor 1 attenuates cisplatin‐induced muscle atrophy in mice	23
Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy	23
Validation of a description of sarcopenic obesity defined as excess adiposity and low lean mass relative to adiposity	23
Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility	22
Prognostic significance of surgery‐induced sarcopenia in the survival of gastric cancer patients: a sex‐specific analysis	22
Muscle mass and estimates of renal function: a longitudinal cohort study	22
Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle	22
Differences in the mass and quality of the quadriceps with age and sex and their relationships with knee extension strength	22
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)	22
Loss of REDD1 prevents chemotherapy‐induced muscle atrophy and weakness in mice	22
Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy	22
Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL‐6 and tumour‐derived extracellular vesicles	21
Motoneuron deafferentation and gliosis occur in association with neuromuscular regressive changes during ageing in mice	21
Renal failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice	21
Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial	21
The composition of the gut microbiome differs among community dwelling older people with good and poor appetite	21
Mitochondria transplant therapy improves regeneration and restoration of injured skeletal muscle	21
The NLRP3 inflammasome contributes to inflammation‐induced morphological and metabolic alterations in skeletal muscle	21
Vitamin D3supplementation does not enhance the effects of resistance training in older adults	21
Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients	21
Causal linkage of tobacco smoking with ageing: Mendelian randomization analysis towards telomere attrition and sarcopenia	21
A randomized, feasibility trial of an exercise and nutrition‐based rehabilitation programme (ENeRgy) in people with cancer	21
Plasma inflammation‐related biomarkers are associated with intrinsic capacity in community‐dwelling older adults	20
Androgen receptor coordinates muscle metabolic and contractile functions	20
Skeletal muscle atrophy‐induced hemopexin accelerates onset of cognitive impairment in Alzheimer's disease	20
Validating muscle mass cutoffs of four international sarcopenia‐working groups in Japanese people using DXA and BIA	20
Iron accumulation in skeletal muscles of old mice is associated with impaired regeneration after ischaemia–reperfusion damage	20
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop	20
The time course of disuse muscle atrophy of the lower limb in health and disease	20
Changes in predicted lean body mass, appendicular skeletal muscle mass, and body fat mass and cardiovascular disease	20
Whole‐body and adipose tissue metabolic phenotype in cancer patients	20
Associations between frailty trajectories and frailty status and adverse outcomes in community‐dwelling older adults	20
Mitochondrial aberrations during the progression of disuse atrophy differentially affect male and female mice	20
Body composition reference ranges in community‐dwelling adults using dual‐energy X‐ray absorptiometry: the Australian Body Composition (ABC) Study	20
Is muscle and protein loss relevant in long‐term fasting in healthy men? A prospective trial on physiological adaptations	20
Sleep duration and progression to sarcopenia in Japanese community‐dwelling older adults: a 4 year longitudinal study	20
Frailty in patients undergoing transcatheter aortic valve replacement: prognostic value of the Geriatric Nutritional Risk Index	20
The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab	20
Recent sarcopenia definitions—prevalence, agreement and mortality associations among men: Findings from population‐based cohorts	19
Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study	19
Influence of vitamin D on sarcopenia pathophysiology: A longitudinal study in humans and basic research in knockout mice	19
Obesity and long‐term outcomes after incident stroke: a prospective population‐based cohort study	19
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia	19
Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin‐deficient and mdx mice	18
Body composition and osteoporotic fracture using anthropometric prediction equations to assess muscle and fat masses	18
Msi2‐mediated MiR7a‐1 processing repression promotes myogenesis	18
Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis	18
Transcriptomic meta‐analysis of disuse muscle atrophy vs. resistance exercise‐induced hypertrophy in young and older humans	18
Malnutrition outweighs the effect of the obesity paradox	18
Chronic aryl hydrocarbon receptor activity phenocopies smoking‐induced skeletal muscle impairment	18
Plasma neurofilament light levels associate with muscle mass and strength in middle‐aged and older adults: findings from GenoFit	18
Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS	18
A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1	18
Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience	18
Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study	18
Sarcopenia as a prognostic indicator of liver cirrhosis	17
Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia	17
Association of anorexia/appetite loss with malnutrition and mortality in older populations: A systematic literature review	17
Phenotypic differences between people varying in muscularity	17
The impact of senescence on muscle wasting in chronic kidney disease	17
Age‐specific and sex‐specific associations of visceral adipose tissue mass and fat‐to‐muscle mass ratio with risk of mortality	17
Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy	17
Sarcopenia and catastrophic health expenditure by socio‐economic groups in China: an analysis of household‐based panel data	17
Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles	17
Diagnosis, prevalence, and outcomes of sarcopenia in kidney transplantation recipients: A systematic review and meta‐analysis	17
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness	17
Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps	17
Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients	17
D3‐creatine dilution for skeletal muscle mass measurement: historical development and current status	17
Ablation of USP21 in skeletal muscle promotes oxidative fibre phenotype, inhibiting obesity and type 2 diabetes	17
Gender differences in risk factors for the 2 year development of sarcopenia in community‐dwelling older adults	16
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study	16
Prognostic score based on physical frailty in patients with heart failure: a multicenter prospective cohort study (FLAGSHIP)	16
Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity	16
Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients	16
Blended home‐based exercise and dietary protein in community‐dwelling older adults: a cluster randomized controlled trial	16
Chemotherapy triggers cachexia by deregulating synergetic function of histone‐modifying enzymes	16
Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system	16
Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma	16
Computed tomography‐defined body composition as prognostic markers for unfavourable outcomes and in‐hospital mortality in coronavirus disease 2019	16
Involvement of Parkin‐mediated mitophagy in the pathogenesis of chronic obstructive pulmonary disease‐related sarcopenia	16
Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis	16
A randomized clinical trial on the effects of exercise on muscle remodelling following bariatric surgery	16
Acute skeletal muscle loss in SARS‐CoV‐2 infection contributes to poor clinical outcomes in COVID‐19 patients	16
Activated mast cells in skeletal muscle can be a potential mediator for cancer‐associated cachexia	16
Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort	16
Sarcopenia and major complications in patients undergoing oncologic colon surgery	16
Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models	16